University Hospital of Berlin Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT01797315
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Universitaetmedizin Berlin, Charité

Active Ingredients

Drugs in Phase 4 Trials (1)

sirolimus (rapamune) (1 trial)

Drugs in Phase 3 Trials (1)

humanised anti-cd22 antibody (1 trial)

Drugs in Other Trials (1)

human milk oligosaccharides (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Skin Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3